Interaction of Cyclooxygenase Isoenzymes, Nitric Oxide, and Afferent Neurons in Gastric Mucosal Defense in Rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 308, Issue 1, 2004, Pages 277-283

  Ehrlich, Karlheinz ^a   Sicking, Christa ^a   Respondek, Michael ^a   Peskar, Brigitta M ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3 FLUOROPHENYL) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL) 2(5H) FURANONE; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CAPSAICIN; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYCLOOXYGENASE 3 INHIBITOR; DEXAMETHASONE; GEMEPROST; HYDROCHLORIC ACID; ISOENZYME; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENACETIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG PROTEIN BINDING; ENZYME BINDING; ENZYME KINETICS; HISTOPATHOLOGY; INHIBITION KINETICS; MALE; NONHUMAN; OXIDATION KINETICS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; SENSITIVITY ANALYSIS; SENSORY NERVE; STOMACH INJURY; STOMACH INNERVATION; STOMACH MUCOSA;

ANIMALS; CYCLOOXYGENASE INHIBITORS; GASTRIC MUCOSA; ISOENZYMES; MALE; NERVE DEGENERATION; NEURONS, AFFERENT; NITRIC OXIDE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RATS; RATS, WISTAR;

EID: 0345866794     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.057752     Document Type: Article

References (40)

1. Boeckxstaens GE, Pelckmans PA, Bogers JJ, Bult H, De Man JG, Oosterbosch L, Herman AG, and Van Maercke YM (1991) Release of nitric oxide upon stimulation of nonadrenergic noncholinergic nerves in the rat gastric fundus. J Pharmacol Exp Ther 256:441-447.
2. Bredt DS, Hwang PM, and Snyder SH (1990) Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature (Lond) 347:768-770.
3. Brown JF, Tepperman BL, Hanson PJ, Whittle BJ, and Moncada S (1992) Differential distribution of nitric oxide synthase between cell fractions isolated from the rat gastric mucosa. Biochem Biophys Res Commun 184:680-685.
4. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, and Simmons DL (2002) COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure and expression. Proc Natl Acad Sci USA 99:13926-13931.
5. Coruzzi G, Coppelli G, Spaggiari S, Cavestro GM, Okolicsanyi L, Lo Giudice P, Pisano C, and Tepperman BL (2002) Gastroprotective effects of amtolmetin guacyl: a new non-steroidal anti-inflammatory drug that activates inducible gastric nitric oxide synthase. Dig Liver Dis 34:403-410.
6. Ehrlich K, Plate S, Stroff T, Gretzer B, Respondek M, and Peskar BM (1998) Peptidergic and cholinergic neurons and mediators in peptone-induced gastroprotection: role of cyclooxygenase-2. Am J Physiol 274:G955-G964.
7. Ferraz JGP, Sharkey KA, Reuter BK, Asfaha S, Tigley AW, Brown ML, McKnight W, and Wallace JL (1997) Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: role in resistance to damage. Gastroenterology 113:195-204.
8. Ferreira SH, Lorenzetti BB, and Correa FM (1978) Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol 53:39-48.
9. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, and Otomo S (1994) NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59.
10. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, and Knowles RG (1997) 1400W is a slow, tight binding and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272:4959-4963.
11. Gretzer B, Ehrlich K, Maricic N, Lambrecht N, Respondek M, and Peskar BM (1998) Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach. Br J Pharmacol 123:927-935.
12. Gretzer B, Maricic N, Respondek M, Schuligoi R, and Peskar BM (2001) Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol 132:1565-1573.
13. Grider JR, Murthy KS, Jin JG, and Makhlouf GM (1992) Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP release. Am J Physiol 262:G774-G778.
14. Hawkey CJ (1999) COX-2 inhibitors. Lancet 353:307-314.
15. Holzer P (1998) Neural emergency system in the stomach. Gastroenterology 114:823-839.
16. Jackson LM, Wu KC, Mahida YR, Jenkins D, and Hawkey CJ (2000) Cyclooxygenase (COX) 1 and 2 in normal, inflamed and ulcerated human gastric mucosa. Gut 47:762-770.
17. Kargman S, Charleson S, Cartwright M, Frank J, Riendeau D, Mancini J, Evans J, and O'Neill G (1996) Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey and human gastrointestinal tracts. Gastroenterology 111:445-454.
18. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, and Herschman HR (1991) TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266:12866-12872.
19. Lambrecht N, Burchert M, Respondek M, Muller KM, and Peskar BM (1993) Role of calcitonin gene-related peptide and nitric oxide in the gastroprotective effect of capsaicin in the rat. Gastroenterology 104:1371-1380.
20. Maricic N, Ehrlich K, Gretzer B, Schuligoi R, Respondek M, and Peskar BM (1999) Selective cyclooxygenase-2 inhibitors aggravate ischemia-reperfusion injury in the rat stomach. Br J Pharmacol 128:1659-1666.
21. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, and Seibert K (1994) Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91:3228-3232.
22. Meade EA, Smith WL, and De Witt DL (1993) Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 268:6610-6614.
23. Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, and Kasuga M (1997) Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112:387-397.
24. Moncada S, Palmer RM, and Higgs EA (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142.
25. O'Neill GP and Ford-Hutchinson AW (1993) Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 330:156-160.
26. Peskar BM, Maricic N, Ehrlich KH, and Sawka N (2002) Reduced injurious activity of amtolmetin guacyl in rats subjected to gastric ischemia-reperfusion. Gastroenterology 122:A230.
27. Raz A, Wyche A, and Needleman P (1989) Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc Natl Acad Sci USA 86:1657-1661.
28. Rees DD, Palmer RM, Schulz R, Hodson HF, and Moncada S (1990) Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101:746-752.
29. Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, et al. (1997) Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol 121:105-117.
30. Sawaoka H, Tsuji S, Tsujii M, Gunawan ES, Nakama A, Takei Y, Nagano K, Matsui H, Kawano S, and Hori M (1997) Expression of the cyclooxygenase-2 gene in gastric epithelium. J Clin Gastroenerol 25:S105-S110.
31. Schmassmann A, Peskar BM, Stettler C, Netzer P, Stroff T, Flogerzi P, and Halter F (1998) Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol 123:795-804.
32. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, Talley JJ, Masferrer JL, Seibert K, and Isakson PC (1998) Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 95:13313-13318.
33. Sternini C, Reeve JR Jr, and Brecha N (1987) Distribution and characterization of calcitonin gene-related peptide immunoreactivity in the digestive system of normal and capsaicin-treated rats. Gastroenterology 93:852-862.
34. Stroff T, Plate S, Seyed Ebrahim J, Ehrlich KH, Respondek M, and Peskar BM (1996) Tachykinin-induced increase in gastric mucosal resistance: role of afferent neurons, CGRP and nitric oxide. Am J Physiol 271:G1017-G1027.
35. Tanaka A, Araki H, Komoike Y, Hase S, and Takeuchi K (2001) Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs. J Physiol (Paris) 95:21-27.
36. Vane J (1994) Towards a better aspirin. Nature (Lond) 367:215-216.
37. Wallace JL, McKnight W, Reuter BK, and Vergnolle N (2000) NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119:706-714.
38. Wallace JL, Reuter B, Cicala C, McKnight W, Grisham MB, and Cirino G (1994) Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 107:173-179.
39. Whittle BJR, Lopez-Belmonte J, and Moncada S (1990) Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 99:606-611.
40. Xie WL, Chipman JG, Robertson DL, Erikson RL, and Simmons DL (1991) Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88:2692-2696.